Other Species / Isoforms
  LOK (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
R11-m1
ANFRRILrLstFEKR
0 1
LOK (human) ANFRRILrLstFEKR R11-m1
LOK (mouse) ANFRRILRLstFEKR R11
LOK (rat) ANFRRILRLstFEKR R11
S13-p
FRRILrLstFEKRKs
Upstream
0 42
Treatment
  • angiotensin_2
  • BI2536
  • ischemia
  • LPA
  • nocodazole
LOK (human) FRRILrLstFEKRKs S13-p
LOK (mouse) FRRILRLstFEKRKs S13-p
LOK (rat) FRRILRLstFEKRKs S13-p
T14-p
RRILrLstFEKRKsR
Upstream
0 62
Treatment
  • angiotensin_2
  • BI2536
  • imatinib
  • nocodazole
  • Su11274
LOK (human) RRILrLstFEKRKsR T14-p
LOK (mouse) RRILRLstFEKRKsR T14-p
LOK (rat) RRILRLstFEKRKsR T14-p
S20-p
stFEKRKsREYEHVR
0 10
LOK (human) stFEKRKsREYEHVR S20-p
LOK (mouse) stFEKRKsREYEHVR S20-p
LOK (rat) stFEKRKsREYEHVR S20-p
K56-ub
KVYKAKNkETGALAA
0 3
LOK (human) KVYKAKNkETGALAA K56-ub
LOK (mouse) KVYKAKNKETGALAA K56
LOK (rat) KVYKAKNKETGALAA K56
K65-ub
TGALAAAkVIETKSE
0 5
LOK (human) TGALAAAkVIETKSE K65-ub
LOK (mouse) TGALAAAKVIETKSE K65
LOK (rat) TGALAAAKVIETKSE K65
K151-ub
ALNFLHSkRIIHRDL
0 1
LOK (human) ALNFLHSkRIIHRDL K151-ub
LOK (mouse) ALNFLHGKRIIHRDL K151
LOK (rat) ALNFLHGKRIIHRDL K151
K159-ub
RIIHRDLkAGNVLMt
0 2
LOK (human) RIIHRDLkAGNVLMt K159-ub
LOK (mouse) RIIHRDLKAGNVLMT K159
LOK (rat) RIIHRDLKAGNVLMT K159
T166-p
kAGNVLMtLEGDIRL
0 1
LOK (human) kAGNVLMtLEGDIRL T166-p
LOK (mouse) KAGNVLMTLEGDIRL T166
LOK (rat) KAGNVLMTLEGDIRL T166
S179-p
RLADFGVsAkNLktL
0 1
LOK (human) RLADFGVsAkNLktL S179-p
LOK (mouse) RLADFGVSAKNLKtL S179
LOK (rat) RLADFGVSAKNLKtL S179
K181-ub
ADFGVsAkNLktLQK
0 15
LOK (human) ADFGVsAkNLktLQK K181-ub
LOK (mouse) ADFGVSAKNLKtLQK K181
LOK (rat) ADFGVSAKNLKtLQK K181
K184-ub
GVsAkNLktLQKRDs
0 6
LOK (human) GVsAkNLktLQKRDs K184-ub
LOK (mouse) GVSAKNLKtLQKRDs K184
LOK (rat) GVSAKNLKtLQKRDS K184
T185-p
VsAkNLktLQKRDsF
0 26
LOK (human) VsAkNLktLQKRDsF T185-p
LOK (mouse) VSAKNLKtLQKRDsF T185-p
LOK (rat) VSAKNLKtLQKRDSF T185-p
S191-p
ktLQKRDsFIGtPyW
0 86
LOK (human) ktLQKRDsFIGtPyW S191-p
LOK (mouse) KtLQKRDsFIGtPYW S191-p
LOK (rat) KtLQKRDSFIGTPYW S191
T195-p
KRDsFIGtPyWMAPE
0 20
LOK (human) KRDsFIGtPyWMAPE T195-p
LOK (mouse) KRDsFIGtPYWMAPE T195-p
LOK (rat) KRDSFIGTPYWMAPE T195
Y197-p
DsFIGtPyWMAPEVV
0 3
LOK (human) DsFIGtPyWMAPEVV Y197-p
LOK (mouse) DsFIGtPYWMAPEVV Y197
LOK (rat) DSFIGTPYWMAPEVV Y197
T208-p
PEVVMCEtMKDTPYD
0 3
LOK (human) PEVVMCEtMKDTPYD T208-p
LOK (mouse) PEVVLCETMKDAPYD T208
LOK (rat) PEVVLCETMKDAPYD T208
T259-p
SDPPTLLtPSkWSVE
0 1
LOK (human) SDPPTLLtPSkWSVE T259-p
LOK (mouse) SDPPTLLTPSKWSVE T259
LOK (rat) SDPPTLLTPSKWSTE T259
K262-ub
PTLLtPSkWSVEFRD
0 1
LOK (human) PTLLtPSkWSVEFRD K262-ub
LOK (mouse) PTLLTPSKWSVEFRD K262
LOK (rat) PTLLTPSKWSTEFRD K262
K277-ub
FLKIALDkNPETRPS
0 1
LOK (human) FLKIALDkNPETRPS K277-ub
LOK (mouse) FLKIALDKNPETRPS K277
LOK (rat) FLKIALDKNPETRPS K277
K301-ub
VSSITSNkALRELVA
0 1
LOK (human) VSSITSNkALRELVA K301-ub
LOK (mouse) VSRVTSNKALRELVA K301
LOK (rat) VSTVTSNKALRELVA K301
T391-p
GDRSLQTtsPPVVAP
0 1
LOK (human) GDRSLQTtsPPVVAP T391-p
LOK (mouse) GDGPLQTTSPADGLS T390
LOK (rat) GDGSPQNTSPADEVS T404
S392-p
DRSLQTtsPPVVAPG
0 5
LOK (human) DRSLQTtsPPVVAPG S392-p
LOK (mouse) DGPLQTTSPADGLSK S391
LOK (rat) DGSPQNTSPADEVSK S405
S413-p
VPVPLRKsRPVsMDA
0 1
LOK (human) VPVPLRKsRPVsMDA S413-p
LOK (mouse) VPVPLRKSRPLsMDA S412
LOK (rat) VPVPLRKSRPLsVDA S426
S417-p
LRKsRPVsMDARIQV
0 23
LOK (human) LRKsRPVsMDARIQV S417-p
LOK (mouse) LRKSRPLsMDARIQM S416-p
LOK (rat) LRKSRPLsVDARIQV S430-p
S438-p
AEQGGDLsPAANRsQ
0 63
LOK (human) AEQGGDLsPAANRsQ S438-p
LOK (mouse) PDQDENPsPAASKSQ S437-p
LOK (rat) TDQAENPSSAASKPP S451
S444-p
LsPAANRsQkAsQsR
0 12
LOK (human) LsPAANRsQkAsQsR S444-p
LOK (mouse) PsPAASKSQKANQsR S443
LOK (rat) PSSAASKPPKVNQSR P457
K446-ub
PAANRsQkAsQsRPN
0 1
LOK (human) PAANRsQkAsQsRPN K446-ub
LOK (mouse) PAASKSQKANQsRPN K445
LOK (rat) under review -
S448-p
ANRsQkAsQsRPNss
Upstream
0 6
Treatment
  • EGF
  • SB202190
LOK (human) ANRsQkAsQsRPNss S448-p
LOK (mouse) ASKSQKANQsRPNss N447
LOK (rat) ASKPPKVNQSRPNSS N461
S450-p
RsQkAsQsRPNssAL
Upstream
0 33
Treatment
  • EGF
  • SB202190
  • SII_angiotensin_2
LOK (human) RsQkAsQsRPNssAL S450-p
LOK (mouse) KSQKANQsRPNssAL S449-p
LOK (rat) KPPKVNQSRPNSSAL S463
S454-p
AsQsRPNssALEtLG
Upstream
0 36
Treatment
  • ischemia
  • JAK_inhibitor_I
  • PI-103
  • SII_angiotensin_2
LOK (human) AsQsRPNssALEtLG S454-p
LOK (mouse) ANQsRPNssALEtLG S453-p
LOK (rat) VNQSRPNSSALETLG S467
S455-p
sQsRPNssALEtLGG
Upstream
0 18
Treatment
  • anti-CD3
  • EGF
  • SB202190
LOK (human) sQsRPNssALEtLGG S455-p
LOK (mouse) NQsRPNssALEtLGG S454-p
LOK (rat) NQSRPNSSALETLGV S468
T459-p
PNssALEtLGGEKLA
0 3
LOK (human) PNssALEtLGGEKLA T459-p
LOK (mouse) PNssALEtLGGEALT T458-p
LOK (rat) PNSSALETLGVETLA T472
S469-p
GEKLANGsLEPPAQA
0 1
LOK (human) GEKLANGsLEPPAQA S469-p
LOK (mouse) GEALTNGGLELPSsV G468
LOK (rat) VETLANGGLELPGSV G482
Q475
GsLEPPAQAAPGPSK
0 1
LOK (human) GsLEPPAQAAPGPSK Q475
LOK (mouse) GGLELPSsVtPSHSK S474-p
LOK (rat) GGLELPGSVTPNHSK S488
A477
LEPPAQAAPGPSKRD
0 1
LOK (human) LEPPAQAAPGPSKRD A477
LOK (mouse) LELPSsVtPSHSKRA T476-p
LOK (rat) LELPGSVTPNHSKRA T490
S485-p
PGPSKRDsDCSSLCT
0 4
LOK (human) PGPSKRDsDCSSLCT S485-p
LOK (mouse) PSHSKRASDCSNLST S484
LOK (rat) PNHSKRASDCSNLST S498
S495-p
SSLCTSEsMDYGTNL
0 1
LOK (human) SSLCTSEsMDYGTNL S495-p
LOK (mouse) SNLSTSESMDYGTSL S494
LOK (rat) SNLSTSESMDYGTSL S508
S514-p
SLNKEMGsLSIKDPK
Upstream
0 22
Treatment
  • EGF
  • vemurafenib
LOK (human) SLNKEMGsLSIKDPK S514-p
LOK (mouse) SLNKETGsLsLKGSK S513-p
LOK (rat) SLNKETGsLSLKGSK S527-p
S516
NKEMGsLSIKDPKLY
0 2
LOK (human) NKEMGsLSIKDPKLY S516
LOK (mouse) NKETGsLsLKGSKLH S515-p
LOK (rat) NKETGsLSLKGSKLH S529
T526
DPKLYKKTLKRtRKF
0 1
LOK (human) DPKLYKKTLKRtRKF T526
LOK (mouse) GSKLHNKtLKRTRRF T525-p
LOK (rat) GSKLHNKTLKRTRRF T539
T530-p
YKKTLKRtRKFVVDG
0 1
LOK (human) YKKTLKRtRKFVVDG T530-p
LOK (mouse) HNKtLKRTRRFVVDG T529
LOK (rat) HNKTLKRTRRFVVDG T543
T543
DGVEVSITTsKIIsE
0 1
LOK (human) DGVEVSITTsKIIsE T543
LOK (mouse) DGVEVSIttsKIISE T542-p
LOK (rat) DGVEVSITTSKIIsE T556
T544
GVEVSITTsKIIsED
0 1
LOK (human) GVEVSITTsKIIsED T544
LOK (mouse) GVEVSIttsKIISED T543-p
LOK (rat) GVEVSITTSKIIsED T557
S545-p
VEVSITTsKIIsEDE
0 2
LOK (human) VEVSITTsKIIsEDE S545-p
LOK (mouse) VEVSIttsKIISEDE S544-p
LOK (rat) VEVSITTSKIIsEDE S558
S549-p
ITTsKIIsEDEKKDE
0 3
LOK (human) ITTsKIIsEDEKKDE S549-p
LOK (mouse) IttsKIISEDEKKDE S548
LOK (rat) ITTSKIIsEDEKKDE S562-p
K621-ub
ENLERQQkQQVEKME
0 2
LOK (human) ENLERQQkQQVEKME K621-ub
LOK (mouse) ENLERQQKQQVEKME K620
LOK (rat) ENLERQQKQQVEKME K634
N666
LMKKEVKNEVEKLPR
0 1
LOK (human) LMKKEVKNEVEKLPR N666
LOK (mouse) QMKKEVKsEVEKLPR S665-p
LOK (rat) QMKKEVKLTVERLAR L679
S679-p
PRQQRKEsMKQKMEE
0 8
LOK (human) PRQQRKEsMKQKMEE S679-p
LOK (mouse) PRQQRKEsMKQKMEE S678-p
LOK (rat) ARNSRNSSSFQEQTE S692
T688-p
KQKMEEHtQkKQLLD
0 1
LOK (human) KQKMEEHtQkKQLLD T688-p
LOK (mouse) KQKMEEHSQKKQRLD S687
LOK (rat) FQEQTEHPQAARRRD P701
K690-ac
KMEEHtQkKQLLDRD
0 1
LOK (human) KMEEHtQkKQLLDRD K690-ac
LOK (mouse) KMEEHSQKKQRLDRD K689
LOK (rat) EQTEHPQAARRRDRD A703
K701-ub
LDRDFVAkQKEDLEL
0 1
LOK (human) LDRDFVAkQKEDLEL K701-ub
LOK (mouse) LDRDFVAKQKEDLEL K700
LOK (rat) RDRDFVAKQKEDLEL K714
K759-ub
QERHQLVkQQLKDQY
0 1
LOK (human) QERHQLVkQQLKDQY K759-ub
LOK (mouse) QERHQLVKQQLKDQY K758
LOK (rat) QERHQLVKQQLKDQY K772
K796-ub
QRMIEQLkVRQQQEK
0 1
LOK (human) QRMIEQLkVRQQQEK K796-ub
LOK (mouse) QRMMEQLKVRQQQEK K795
LOK (rat) QRMMEQLKVRQQQEK K809
K823-ub
TRMAMYKksLHINGG
0 1
LOK (human) TRMAMYKksLHINGG K823-ub
LOK (mouse) TRMAMYKKSLHINGA K822
LOK (rat) TRMAMYKKSLHINGA K836
S824-p
RMAMYKksLHINGGG
0 1
LOK (human) RMAMYKksLHINGGG S824-p
LOK (mouse) RMAMYKKSLHINGAG S823
LOK (rat) RMAMYKKSLHINGAG S837
K841-ub
AEQREKIkQFsQQEE
0 1
LOK (human) AEQREKIkQFsQQEE K841-ub
LOK (mouse) SEQREKIKQFSQQEE K840
LOK (rat) SEQREKVKQFSQQEE K854
S844-p
REKIkQFsQQEEkRQ
Upstream
0 1
Treatment
  • nocodazole
LOK (human) REKIkQFsQQEEkRQ S844-p
LOK (mouse) REKIKQFSQQEEKRQ S843
LOK (rat) REKVKQFSQQEEKRQ S857
K849-ub
QFsQQEEkRQKSERL
0 1
LOK (human) QFsQQEEkRQKSERL K849-ub
LOK (mouse) QFSQQEEKRQKAERL K848
LOK (rat) QFSQQEEKRQKAERL K862
S951-p
EAECPNPstPsKAAK
0 7
LOK (human) EAECPNPstPsKAAK S951-p
LOK (mouse) EEAEPRPTtPsKASN T949
LOK (rat) EEAETRPttPNRASK T963-p
T952-p
AECPNPstPsKAAKF
Upstream
0 110
Treatment
  • selumetinib
  • U0126
  • vemurafenib
LOK (human) AECPNPstPsKAAKF T952-p
LOK (mouse) EAEPRPTtPsKASNF T950-p
LOK (rat) EAETRPttPNRASKF T964-p
S954-p
CPNPstPsKAAKFFP
0 20
LOK (human) CPNPstPsKAAKFFP S954-p
LOK (mouse) EPRPTtPsKASNFFP S952-p
LOK (rat) ETRPttPNRASKFFP N966
Y962-p
KAAKFFPySSADAs_
0 1
LOK (human) KAAKFFPySSADAs_ Y962-p
LOK (mouse) KASNFFPYSsGDAS_ Y960
LOK (rat) RASKFFPYSSGDAS_ Y974
S964
AKFFPySSADAs___
0 1
LOK (human) AKFFPySSADAs___ S964
LOK (mouse) SNFFPYSsGDAS___ S962-p
LOK (rat) SKFFPYSSGDAS___ S976
S968-p
PySSADAs_______
0 1
LOK (human) PySSADAs_______ S968-p
LOK (mouse) PYSsGDAS_______ S966
LOK (rat) PYSSGDAS_______ S980